BRAIN & HEART LIMITED
🌿Early-stageactive
SC715691 · ltd · incorporated 2021-11-22
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Nov 2024
Net worth
£177.4k
book net assets
Opportunity
70/100
Strong
What this business does
Primary activity: General medical practice activities
Sector: Human health & social work
Investor take
PursueStrong opportunity: asset-holding vehicle with strong profile and acceptable with review structure.
Opportunity 70/100 (strong), bankability 70/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
Network not yet resolved
30
Filing history
8 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
70/100Strong
PassWatchWorth a lookStrongExceptional
Solid opportunity signal. Worth a dedicated memo and management meeting.
Business quality
60
Adequate — check latest filings for context.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredPositive net assets
Net assets £177,389
Cash YoY
+62%
Year on year
Key financials
2 years extracted from filed iXBRL accountsCash
£194k
↑ 62% YoY
Net Worth
£177k
↑ 30% YoY
Current Assets
£230k
↑ 61% YoY
Current Liabilities
—
Hover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2024-11-30 | 2023-11-30 |
|---|---|---|
| Total assets | £241.6k | £210.9k |
| Current assets | £229.8k | £142.6k |
| Cash | £193.6k | £119.3k |
| Debtors | £36.2k | £23.3k |
| Net assets | £177.4k | £135.9k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
🔒Filing-note intelligence
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
1
filing
- • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (7 events)Click to expand
- 2025-03-25📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-04-16📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-06-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-11-22🏢Company incorporatedAs BRAIN & HEART LIMITED
- 2021-11-22➕GIAMOURIADIS, Anastasios appointeddirector
- 2021-11-22➕GIAMOURIADIS- BATTLE, Chloe Marie appointeddirector
- 2021-11-22📄incorporation-companyincorporation · NEWINC
Owner dependency
58/100
Moderate — manageable with handoverSome founder dependency, but not acute. A structured handover period should cover most risk.
FACTORS
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
Succession & seller-readiness
36/100
Weak signalLimited succession signal. Not a near-term off-market candidate.
SIGNALS
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanNo red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)
Shareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Anastasios Giamouriadis Individual · Greek · DOB 09/1980 · age 46 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 22/11/2021 |
Mrs Chloe Marie Giamouriadis- Battle Individual · British · DOB 04/1989 · age 37 | 25–50% | 25–50% | board control25-50% shares · 25-50% voting · board control | 22/11/2021 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · AB postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| CHERRY BLOSSOM CHILDREN’S RESIDENTIAL HOME LTD→ SC667800 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| CLAREMONT ANAESTHESIA LIMITED→ SC809858 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| CONTINUITY CARE SCOTLAND LTD→ SC626674 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| COVE SMILE SOLUTIONS LTD→ SC876606 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| CREATE ABERDEEN→ SC380533 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| CTEV INITIATIVE LIMITED→ SC704847 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| DGASCEND LIMITED→ SC861877 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| DYNAMIC THERAPY COLLECTIVE LTD→ SC743999 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| EDINBURGH BREAST SURGEONS LTD→ SC569965 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| EMERALD & PEARLS LIMITED→ SC712341 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| EMMASAM LIMITED→ SC458881 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| EMPOWER PHYSIO & MASSAGE THERAPY LTD→ SC866172 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2021-11-22
Jurisdictionscotland
Primary SIC86210 — General medical practice activities
Registered office
5 Carden Place
Aberdeen
AB10 1UT
Scotland
Filing status
Accounts
Next due: 2026-08-31
Last made up to: 2024-11-30
Confirmation statement
Next due: 2026-12-05
Last: 2025-11-21
Officers (2 active · 0 resigned)
GIAMOURIADIS, Anastasios→
Activedirector · ~46y · appointed 2021-11-22
View their other companies + combined net worth →
GIAMOURIADIS- BATTLE, Chloe Marie→
Activedirector · ~37y · appointed 2021-11-22
View their other companies + combined net worth →
Click a director name to see their full track record across all companies.
Recent filings (8 total)
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-12-04
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-03-25
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-11-25
accounts-with-accounts-type-total-exemption-full
accounts · AA
2024-04-16
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-11-23
accounts-with-accounts-type-total-exemption-full
accounts · AA
2023-06-29
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-11-21
incorporation-company
incorporation · NEWINC
2021-11-22